Looking back over a century of progress, Vas Narasimhan, Novartis CEO, explores how the medicines we know today have evolved.
Vas outlines how innovations in small molecules, protein therapies and monoclonal antibodies changed the landscape of medicine and how the biopharmaceutical industry continues to advance at an unprecedented pace.
Learn more: https://bit.ly/3CEPS8e
©2022 Novartis AG
Source Novartis YouTube
